EVO - Evotec SE (EVO) Q4 2023 Earnings Call Transcript
2024-04-24 16:36:03 ET
Evotec SE (EVO)
Q4 2023 Earnings Conference Call
April 24, 2024 9:00 AM ET
Company Participants
Volker Braun - Head of Global Investor Relations and ESG
Iris Löw-Friedrich - Chairperson of the Supervisory Board
Laetitia Rouxel - Chief Financial Officer
Matthias Evers - Chief Business Officer
Craig Johnston - Chief Operating Officer
Conference Call Participants
Peter Verdult - Citigroup Inc.
Charles Weston - RBC Capital Markets
Michael Ryskin - Bank of America
Jacqueline Kisa - TD Cowen
Falko Friedrichs - Deutsche Bank
Naresh Chouhan - Intron Health
Joseph Hedden - Rx Securities
Presentation
Operator
Ladies and gentlemen, welcome to the Evotec SE Annual Report 2023 Conference Call. I’m Moritz Nikolaus, call operator. I would like to remind you that all participants will be in a listen-only mode, and the conference is being recorded. [Operator Instructions]
At this time, it’s my pleasure to hand over to Volker Braun, Head of IR and ESG. Please go ahead, sir.
Volker Braun
Thank you, Moritz. And good day, good morning to all of you on the call. I’m sure you all have seen our press release on our 2023 results this morning, as well as the announcement last night on the appointment of Dr. Christian Wojczewski, who will be our new CEO of 1st of July. This development is the reason why we also have Iris Löw-Friedrich, our Chairwoman of the Supervisory Board, with us on the call today.
But before we go there, it’s my obligation to familiarize you with the cautionary language we have outlined on Page 2. But now, without further ado, I would like to hand over to Iris. Please, Iris, the floor is yours.
Iris Löw-Friedrich
Yeah, Volker, thank you very much. And very warm welcome to all of you also from my side. We are ready to win the future for Evotec. Our core offerings are in high demand. Our business model is solid. Business is growing. We focus on profitability. And most importantly, we have a super strong team in place, and we are strengthening the leadership in Evotec further. And that’s the reason why I participate as the Chair of the Supervisory Board in a regular full year results call today.
So with me today, Laetitia Rouxel, our Chief Financial Officer, who will cover the review on Evotec’s performance in 2023; followed by Matthias Evers, our Chief Business Officer, who will guide you through the rationale and the details of the reset of the company’s priorities for the coming year. Our Chief Operating Officer, Craig Johnston; and our Chief Scientific Officer, Cord Dohrmann, will stand by to answer any questions you may want to address to them during the Q&A session....
Evotec SE (EVO) Q4 2023 Earnings Call Transcript